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Introduction. Appropriate adherence to medication is still a challenging issue for hypertensive patients. We determined adherence
to antihypertensive(s) and its associated factors among 280 Iranian patients. Methods. They were recruited consecutively from
private and university health centers and pharmacies in four cities.The validated Persian version of the 8-itemMoriskyMedication
Adherence Scale (MMAS-8) was administered to measure adherence. Results. Mean (±SD) overall MMAS-8 score was 5.75 (±1.88).
About half of the sample (139 cases, 49.6%) showed low adherence (MMAS-8 score < 6). There was a negative linear association
between the MMAS-8 score and systolic BP (𝑟 = −0.231, 𝑃 < 0.001) as well as diastolic BP (𝑟 = −0.280, 𝑃 < 0.001). In
linear regression model, overweight/obesity (𝐵 = −0.52, 𝑃 = 0.02), previous history of admission to emergency services due
to hypertensive crisis (𝐵 = −0.79, 𝑃 = 0.001), and getting medication directly from drugstore without refill prescription in hand
(𝐵 = −0.51, 𝑃 = 0.04) were factors recognized to have statistically significant association with the MMAS-8 score. Conclusion.
Antihypertensive adherence was unsatisfactory. We suggest that health care providers pay special attention and make use of the
aforementioned findings in their routine visits of hypertensive patients to recognize those who are vulnerable to poor adherence.
1. Introduction
Hypertension (HTN) is a major public health challenge in
many parts of the world [1]. Left uncontrolled, HTN poses
serious health problems on sufferers including heart attack,
heart failure, and stroke [2]. Health care providers should
make use of all armamentariums available for better control
of HTN. Beside regular checkups, medication intensification,
health surveillance, and patient education, a factor that health
care providers should be more aware about in facing this
population is assessing the extent to which hypertensive
patients comply withmedications as prescribed for them (i.e.,
adherence to medication) [3].
Considering the fact that there are effective medications
available to control HTN and the aggressive stance required
with hypertensive patients, we think that assessing the issue
ofmedication adherence could be an integral part ofmanage-
ment of such patients. In other words, medication adherence,
although a complex issue with various associated factors,
is a very critical component in controlling blood pressure
(BP) of patients within the recommended normal ranges
and consequently achieving good health outcome in long
term and holding up the cardiovascular complications [4].
Nonadherence has been noted as one of the contributing
factors in uncontrolled BP [5].
The pertinent literature review from different coun-
tries revealed that adherence to medications prescribed
for patients with high BP may not be satisfactory. Good/
acceptable adherence, determined via various tools, has been
reported as 15.8% [6], 20.3% [7], 43.1% [8], 43.7% [9],
46% [10], 53% [11], 58% [12], and 77% [13]. As seen, most
studies reported that good adherence to antihypertensives
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was documented in half of the patients studied. Most of the
aforementioned studies also conceded that poor medication
adherence was significantly associated with uncontrolled BP.
Hitherto, studies regardingmedication adherence among
hypertensive patients from Iran are insufficient. There are
reports that a substantial proportion of patients have uncon-
trolled BP, reportedly 56.3% [14], 62% [15], and 65% [16].
In a comparative analysis carried out on data from national
surveys of 20 countries, Iran was recognized as one of the
countries with poor diagnosis and control of HTN [17]. With
respect to lack of enough information about this issue in Iran,
we intended to determine the antihypertensive adherence
status of a sample of Iranian patients with HTN and find out
any allied significant factor contributing to low medication
adherence.
2. Materials and Methods
This cross-sectional study lasted from August to December
2014. This was a multicenter study including tertiary referral
center of university-affiliated hospital, private cardiology
office, pharmacy, and private general practitioner office
in the cities of Tehran, Karaj, Kermanshah, and Bafgh.
Inclusion criteria were adult patients of either gender who
had documented HTN and were taking antihypertensive
medications. The patients were interviewed directly at health
centers or offices upon their presentation for checking their
BP or to refill their prescriptions. A coordination session
was held before the study initiation and the participating
doctors and pharmacists were instructed by the principal
investigator to interview any patient meeting the inclusion
criteria consecutively during their daily visit of the patients
in predetermined research locations. The pharmacists were
asked to refer the eligible subjects to one of the nearest
physicians involved in this research. For known patients for
whom a medical record existed, in addition to the interview,
other pertinent data were extrapolated from their records and
were documented in the forms.
To determine the adherence to antihypertensives, the
Persian version of the MMAS-8 which was validated by our
team in a previous study was administered to the patients.
The MMAS-8 was developed as a simple and reliable tool
which can be used by clinicians to determine the adherence
of patients to prescribed medications [18]. The 8-item scale
was originally studied in hypertensive patients and the results
revealed that it was a reliable (𝛼 = 0.83) tool and showed
significant correlation with BP control (𝑃 < 0.05). It showed
a sensitivity of 93% in detecting patients with poor BP control
[19]. In our previous study on 200 Iranian patients who were
suffering from HTN, we determined the Persian version of
the MMAS-8 to be valid and reliable tool with an overall
Cronbach’s 𝛼 coefficient of 0.697 and test-retest reliability
showed good reproducibility (𝑟 = 0.940) [20].
In addition to the MMAS-8, a checklist was designed by
the authors to gather demographic as well as variables about
other diseases or medications the patients were taking. First,
the MMAS was completed by the patients. If the patient was
illiterate, the researcher read the questions for the patient
and asked him/her to answer the questions orally. Then
the correspondent answer was marked by the researcher
on the MMAS and checklist. After completing the MMAS,
the checklist data was completed. The data included in
the checklist were demographic data (age, gender, weight,
height, occupation, and educational level), duration of HTN,
medications prescribed for HTN, other comorbidities, other
medications other than antihypertensives, and control of
HTN during the last 6 months by a health care provider.
One of the variables included in the checklist was history of
HTN crisis, in the form of emergency or urgency, leading to
emergency admission. This variable was investigated using
themedical records available at the research location or those
from other medical centers in the past. Only documented
reports/discharge notes signed by medical professionals con-
taining detailed informationwere used to decide the previous
history of HTN crisis. At the end, BP of the patients was
measured by the researchers using a sphygmomanometer on
the left arm when the patient was in seated position. The
patients were asked to seat relaxed and not smoke for half an
hour before BP recording. Korotkoff sounds were the basis
to define systolic and diastolic BP. For the purpose of this
study, brand new sphygmomanometers were provided to the
doctors and an educational video was displayed and reviewed
to ensure the lowest level of variation between BP readings by
the research team members.
2.1. Statistical Analyses. All gathered data were entered into
the SPSS software for Windows (ver. 18.0) (SPSS Inc.,
Chicago, IL). To express the results, we used descriptive
indices including mean and its standard deviation (SD),
frequency and percentage. Regarding the MMAS-8 score,
we divided the patients into two groups of low adherence
(i.e., MMAS-8 score of less than 6) versus moderate/high
adherence (i.e.,MMAS-8 scores of 6–8).TheChi-squared and
Mann-Whitney𝑈 tests were applied to compare, respectively,
the gathered categorical and continuous data between these
two groups of MMAS-8 scores. To find any relationship
between controlled BP (i.e., systolic BP < 140 and diastolic
BP < 90mmHg in nondiabetics and < 130/80mmHg in
diabetics) and MMAS score, the Pearson correlation test was
used. Significance level was set at 0.05. To find correlation
between systolic and diastolic BP values and the MMAS-
8 score, Spearman’s rho test was used. A multiple logistic
regression analysis was done to predict effective variables that
can affect poor drug adherence. In this analysis, all variables
were indicated as independent and poor drug adherence (i.e.,
MMAS score < 6) was indicated as the dependent variable.
2.2. Ethics. Firstly, the objective of the study was explained
to the patients. If the patient was interested in contributing
to the study and gave his/her oral consent, then instructions
about how to complete the MMAS-8 and the demographic
form were provided to them. They were assured that the
information will be used only for scientific purposes. The
protocol of the study was in conformity with the Helsinki
Declaration.
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(𝑁 = 141) Sig.
Gender
Male 118 (42.1%) 59 (50%) 59 (50%) 0.919
Female 162 (57.9%) 80 (49.4%) 82 (50.6%)
Age, years
≤50 51 (18.2%) 25 (49%) 26 (51%) 0.922
>50 229 (81.8%) 114 (49.8%) 115 (50.2%)
BMI, kg/m2
<25 76 (27.1%) 28 (36.8%) 48 (63.2%) 0.011
≥25 204 (72.9%) 111 (54.4%) 93 (45.6%)
Education
Lower than high school diploma/illiterate 164 (58.5%) 86 (52.4%) 78 (47.6%)
0.008High school diploma 71 (25.4%) 40 (56.3%) 31 (43.7%)
Academic degree 45 (16.1%) 13 (28.9%) 32 (71.7%)
Occupation
Market/self-employed 73 (26.1%) 43 (58.9%) 30 (41.4%)
0.001Clerk/military 41 (14.6%) 9 (22.0%) 32 (78.0%)
Housewife 119 (42.5%) 65 (54.6%) 54 (45.4%)
Retired/unemployed 47 (16.8%) 22 (46.8%) 25 (53.2%)
Current smoker 49 (17.5%) 29 (59.2%) 20 (40.8%) 0.141
Insurance coverage 246 (87.8%) 119 (48.4%) 127 (51.6%) 0.253
Residence place
Urban 273 (97.5%) 133 (48.7%) 140 (51.3%) 0.053
Rural 7 (2.5%) 6 (85.7%) 1 (14.3%)
Sig. = significance level.
3. Results
In total, 280 patients were included. Mean (±SD) age of
the participants was 60.3 (±10.0) years, 118 cases (42.1%)
were male, 204 (72.9%) were overweight/obese (BMI values
of ≥25 kg/m2), 164 (58.5%) had education level below high
school diploma or were illiterate, and 49 (17.5%) were cur-
rent smokers. Mean (±SD) overall MMAS-8 score was 5.75
(±1.88). About half of the sample (139 cases, 49.6%) showed
low adherence to antihypertensives. Ninety-five cases (33.9%)
had moderate adherence and 46 cases (16.4%) showed high
adherence.
Table 1 presents demographic characteristics of the
sample and comparison of these data between low and
medium/high adherence groups. As depicted, there was
higher percentage of patients with BMI values of less than
25 kg/m2 in moderate/high adherence group compared to
low adherence group. Also, those who had received academic
training and had occupations as clerk or inmilitary personnel
represented better adherence. However, considering other
demographic information including gender, age, having an
insurance coverage, residential place (urban areas versus
rural ones), and being a smoker did not reveal significant
difference between low and moderate/high adherers.
Mean (±SD) duration of HTNwas 7.2 (±5.9) years (range,
6 months to 40 years). General practitioner (67 cases, 23.9%)
and cardiologist (65 cases, 23.2%) were the most common
presented physicians whose patients reported that they visit
to control their high BP. Others reported visiting internist (24
cases, 8.6%), nephrologist (9 cases, 3.2%), or more than one
physician to check their BP (115 patients, 41.0%). According
to the criteria, 122 patients out of 280 cases (43.6%) had
controlled BP. Among diabetics (i.e., 55 hypertensive diabet-
ics with/without other concomitant conditions), only 2 cases
(3.6%) had controlled BP. Table 2 shows comparison of BP-
related variables between low and moderate/high adherers.
As seen, those who were low adherers had higher percentage
of hypertensive crisis (hypertensive emergency or urgency)
which required admission to hospital emergency services,
lower rate of visiting their doctors to get their BP checked
during the preceding 6 months from the study, and higher
systolic and diastolic BP measurements when compared to
moderate/high adherers. Controlled BPwas also significantly
higher in moderate/high nondiabetic adherers compared to
those who had lowMMAS-8 score. About diabetics, since the
sample size was not enough, statistical significance was not
seen.
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(𝑁 = 141) Sig.
HTN duration, mean (±SD), year 7.23 (±5.97) 7.06 (±5.71) 7.40 (±6.23) 0.966
History of HTN crisis 99 (35.3%) 62 (62.5%) 37 (37.4%) 0.001
BP measurement by a health care
provider in the last 6 months 230 (82.1%) 107 (46.5%) 123 (53.5%) 0.025
Self-awareness of BP 161 (57.5%) 81 (50.3%) 80 (49.7%) 0.795
Mean systolic BP, mmHg 136.7 (±16.2) 139.6 (±15.2) 133.8 (±16.8) 0.003
Mean diastolic BP, mmHg 83.9 (±9.0) 85.7 (±8.3) 82.1 (±9.2) <0.001
Controlled BP in nondiabetics 120 49 (40.8%) 71 (59.2%) <0.001
Controlled BP in diabetics 2 0 2 (100%) 0.504







(𝑁 = 141) Sig.
Antihypertensive therapy
Monotherapy 127 (45.3%) 68 (53.5%) 59 (46.5%) 0.234
Combination therapy 153 (54.6%) 71 (46.4%) 82 (53.6%)
Number of antihypertensive(s)
classes taken
1 127 (45.3%) 68 (53.5%) 59 (46.5%)
0.0792 95 (34%) 37 (38.9%) 58 (61.1%)
3–5 58 (20.7%) 34 (58.6%) 24 (41.4%)
Presence of comorbidity 160 (57.1%) 77 (48.1%) 83 (51.9%) 0.629
Mean (±SD) number of
comorbidities,𝑁 = 160 patients
with at least one comorbidity
1.54 (±0.76) 1.53 (±0.75) 1.54 (±0.77) 0.984
Taking anti-hypertensive from
pharmacy without doctor visit 212 (75.7%) 113 (53.3%) 99 (46.7%) 0.031
Nearly half of the cases (127 patients, 45.3%) were taking
one class of antihypertensive for their condition. Among
these, angiotensin-receptor blocker (74 cases, 26.4%) was
the most prevalent medication used, followed by selective
beta-blockers (22 cases, 7.9%), hydrochlorothiazide (13 cases,
4.6%), angiotensin-converting enzyme inhibitor (10 cases,
3.6%), calcium-channel blocker (7 patients, 2.5%), and finally
alpha-blocker (one patient, 0.4%). Others (153 cases, 54.6%)
were taking more than one class of antihypertensive to
control their high BP. One-hundred sixty patients (57.1%)
had a concomitant condition other than HTN. The most
common comorbidity was ischemic heart disease (with or
without having undergone coronary artery bypass grafting
(CABG) or minimally invasive percutaneous interventions;
PCI) which was documented in 28 patients (10.0%). Then,
diabetes mellitus (23 cases, 8.2%) and dyslipidemia (12
cases, 4.3%) were, respectively, most common comorbidities.
Most patients (212 patients, 75.7%) reported that they had
presented to pharmacies during the last 6 months to take
their medication without controlling their BP by their doc-
tor. In Table 3, comparison of antihypertensives taken and
comorbidities between low and moderate/high adherers is
presented. As observed, no association was detected between
number of antihypertensives or number of comorbidities
and medication adherence categories. The only statistically
significant association was observed regarding those who
reported that they personally without visiting their doctors
requested the pharmacist to refill their prescription or in
some cases, even without prescription in hand, purchased
their medication directly from the drugstore.
There was a negative linear association between the
MMAS-8 score and systolic BP (𝑟 = −0.231, 𝑃 < 0.001) as
well as diastolic BP (𝑟 = −0.280, 𝑃 < 0.001). Table 4 shows
linear regression model results. Being overweight or obese,
previous history of admission to emergency services due
to hypertensive crisis, and getting medication directly from
drugstore without refill prescription in hand were factors
recognized to have statistically significant association with
the MMAS-8 score.
4. Discussion
Good adherence to antihypertensives is a key factor in
achieving appropriate BP control in hypertensive patients.
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Table 4: Linear regression analysis of variables associated with the MMAS-8 score.
𝐵 Standard error of 𝐵 Significance
History of HTN crisis −0.796 0.228 0.001
Taking antihypertensive from pharmacy without doctor visit −0.515 0.251 0.041
BMI ≥ 25 kg/m2 −0.523 0.237 0.028
Constant 9.764 0.913 0.001
BMI = body mass index; HTN = hypertension.
The results obtained here show that compliance with anti-
hypertensive(s) is not satisfactory among Iranian hyperten-
sive patients. The rate of controlled BP and the signifi-
cant association detected between systolic and diastolic BP
measurements with adherence level support this finding. In
other words, poor adherence affected negatively BP control.
Adherence studies from Iran are not sufficient in terms of
quantity and quality. The limited literature has noted diverse
designs and tools to define adherence and subsequently direct
comparison with the current results may not be feasible.
According to a review article, though there has been good
effort to determine adherence to diabetes medicines, no high
quality study has been done so far in Iran on hypertensive
patients. In particular, the tools used to define adherence
included pill counting and self-reported questionnaire [21]. It
has been noted that methods such as 24-hour recall and refill
history do not accurately measure medication adherence
[22]. We administered the MMAS-8 to define medication
adherence. This scale has been established in several studies
across different cultures and languages and various popula-
tions to be a reliable tool in determining adherence [6, 7, 23–
25]. As mentioned above, we observed a good reliability and
validity of this scale in Persian speaking patients in a previous
study [20].
In a former study on 250 patients with high BP in Shiraz
city, Iran, using a self-report questionnaire and ratio of taken
pills to prescribed pills in one-month period, it was found
that having a positive attitude toward antihypertensives and
the interval between visits to physician of less than 3 months
were two independent predictors of good adherence [26].
We did not study attitude or knowledge of the patients here,
but about 40% of the patients reported that they had visited
more than one doctor to control their BP. Adding this to the
figure of one-fifth of the cases who had never scheduled an
appointment to visit their doctors during the preceding 6
months of the study may reflect faults in health care system.
Reviewing the literature, it seems that there is no general
consensus among experts and scientific organizations about
visit frequency in hypertensive patients, but studies confirm
the fact that shorter intervals yield better BP control and
earlier normalization [27, 28].
In a study on older adults with HTN and using the
Morisky 4-Item Self-Report Measure of Medication-Taking
Behavior (MMAS-4), the authors found that older people
with a comorbidity and longer history of HTN had better
adherence. These are in contrast to our finding as age, pres-
ence of comorbidity or its number and duration of HTNwere
not different between poor andmoderate/good adherers.This
may be due to different scales to define adherence (MMAS-
4 in Chinese study versus MMAS-8 in our study) and the
nature of patients studied in the mentioned article which
included only those who aged more than 55 years. The only
similar finding was higher educational level in both studies
which was associated with better adherence. The finding
that the number of antihypertensives did not associate with
adherence is compatible with an Indian study performed in
a tertiary care center [29]. They, similar to what we found
here, reported that those who had experienced symptoms of
HTN were significantly more likely to have low adherence to
antihypertensives. In our opinion, this is a mutual relation-
ship that patients who do not take their medicines regularly
are more likely to experience hypertensive crisis and need
for admission to get inpatient treatment. The same patients
who were interviewed at a later date were still found to be
nonadherent. It could be inferred that, despite experiencing
hypertensive crisis, the patients’ attitude and practice regard-
ing taking his/her antihypertensive is not changed and they
are still considered poor adherers. Likewise, the Indian article
did not find any association between number of antihyper-
tensives taken daily and adherence. This is contradictory to
what was reported by a Pakistani study where it was found
that higher number of patients who were taking two drugs
(82% versus 18%) ormore than 3 drugs (87% versus 12%)were
adherent when compared to low adherers. They used the 4-
item MMAS to define adherence level [13]. Self-medication
and self-prescription are two quite widespread practices in
Iranian patients. Although governmental authorities have
consistently warned publicly about self-medication health
hazards and despite advice from experts to pass legislations
to limit easy access to prescription-only medications [30],
unfortunately this problem still remains a health problem
in Iran. Former studies on this topic focused mainly on
antibiotic and analgesic self-medication which reported high
prevalence of this public health concern [31]. In a similar
fashion, we observed a high number of the cases who
reported self-prescription and that this sample had lower
adherence level. It is important to note that adherence to
medication is one of the factors that contribute to acceptable
BP control. There are other factors such as patient education,
correct intensification of medication, and economic issues
that determine good BP control [5].
We suggest that future studies focus on antihypertensive
self-medication and related behavioral, economic, and social
factors. It is also prudent to compare various methods to find
the most effective to raise medication adherence in Iranian
hypertensive patients.
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Regarding strengths and limitations we faced here, in our
opinion, the fact that the data were gathered from several
health centers as well as pharmacies in different cities would
enable us to generalize the data in a better form to the Iranian
community. Particularly, the city of Karaj which is located
about 30 km from the capital, Tehran, has faced an increasing
growth in its population during the last 2 decades, mainly as
a result of immigration from other cities.
The limitation here to be considered is that adherence
is a complex phenomenon and various factors can affect
that. For instance, patient awareness and knowledge about
HTN and medicines prescribed, the role of the physicians
in providing information and patient education, behavioral
and psychological factors, doctor-patient relationship, and
the like are potential factors that can be investigated in more
detail in the future studies. Another limitation is related to
BP recording. Since this study was done in different centers
and BP recording was based on measurement by sphygmo-
manometer and taken by different physicians, it is likely
that there might be variations in devices and maybe some
variations, though we think not very significant, differences
in BP readings. Our resources and limited time did not allow
us to implement more accurate devices for BP monitoring
such as Holter monitor.
5. Conclusion
Adherence to antihypertensive(s) among Iranian patients
is not satisfactory and more than half of the patients had
uncontrolled BP which was in direct relationship with poor
adherence to medications. The patients who were over-
weight/obese, who had been admitted to hospital or clinic
emergency services because of HTN crisis, housewives or
those who were unemployed or retired, those with lower
educational level, and those getting their medication directly
from pharmacies without visiting their doctors to control
their BP and refill prescription in hand were more likely to be
low adherers. We recommend that health care professionals
who manage hypertensive patients consider these factors
during their routine visit of such patients in an attempt to
alert the patients for better adherence.
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